Cognitive factors associated with willingness to receive three important vaccines among older adults: A protection motivation theory perspective
Abstract
ABSTRACT Vaccines against influenza, pneumococcal pneumonia, and herpes zoster are pivotal for infectious disease control in older adults, yet vaccination coverage remains suboptimal. Guided by Protection Motivation Theory (PMT), this cross-sectional study identified cognitive factors of overall willingness toward the three important vaccines among adults aged ≥60 y, to inform population-level intervention strategies. A representative sample of 420 older adults was recruited from Chengdu, China, via multistage stratified sampling between August and October 2024. Partial least squares structural equation modeling was applied to analyze associations between PMT cognitive constructs, health status, and overall vaccination willingness. Results showed moderate overall willingness to receive the three vaccines (16.7 ± 5.0, range: 5–25), with PMT explaining 57.6% of its variance (R2 = 0.576). Four PMT cognitive factors significantly predicted vaccination willingness: three had positive associations – perceived vulnerability (b = 0.128, p < .01), self-efficacy (b = 0.396, p < .001), and response efficacy (b = 0.289, p < .001) – with self-efficacy being the strongest predictor; whereas response cost (b = −0.102, p < .01) exerted a negative effect. Health status moderated the perceived severity → vaccination willingness pathway (diff b = −0.189, p < .05); specifically, perceived severity positively correlated with willingness among older adults with poor health (b = 0.143, p < .05).…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 420 participants or records.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.